Skip to main content
TipRanks
Go Ultimate75% OFF

Koken Ltd. (7963) AI Stock Analysis

0 Followers
JP:7963

Koken Ltd.

(TSE/TYO:7963)

Select Model
Rating:60Neutral
Price Target:JPY 1,712.00â–²(3.38% Upside)
Action:reiterated
Date:11/08/26

The overall score is constrained by a significant divergence between fundamentals and market action. The primary risk is the extremely weak technical picture, with the stock in a deep downtrend and showing strong bearish momentum. This is compounded by a critical deterioration in cash flow, despite solid income statement growth. Mitigating these concerns is a very attractive valuation, with a single-digit P/E and a high dividend yield, which may provide a floor for the stock if cash flow trends reverse.

Positive Factors
Reaccelerating RevenueThe return to meaningful revenue growth after a flat 2023 and modest 2024 indicates improving demand and renewed commercial momentum. If sustained, stronger top-line expansion can support operating leverage, fund investment, and reinforce the company’s position in medical devices over the next several quarters.
Negative Factors
Negative Free Cash FlowNegative free cash flow materially weakens the company’s ability to self-fund operations, investment, and shareholder returns despite reported profitability. If this persists, Koken may need to draw on its balance sheet or external financing, reducing flexibility and making earnings less valuable to long-term owners.

Koken Ltd. (7963) vs. iShares MSCI Japan ETF (EWJ)

-10%0%10%20%30%JP:7963-8.08%EWJ+16.02%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 7.94B
Dividend Yield
3.02%
Average Volume (3M)
4,346
Price to Earnings (P/E)
9.8
Beta (1Y)
0.38
Revenue Growth
8.56%
EPS Growth
7.14%
Country
Japan
Employees
312
Sector
General
Sector Strength
55
Industry
Medical - Devices

Koken Ltd. Business Overview & Revenue Model

Company Description

Koken Ltd., along with its subsidiaries, specializes in the production and sale of personal protective equipment for occupational use and products designed to enhance environmental quality throughout Japan. The company organizes its diverse operation...

How the Company Makes Money

null

Koken Ltd. Financial Statement Overview

Summary

Solid revenue growth (+7.2%) and net income surge (+22.6%) with stable margins are offset by a severe deterioration in cash flow. Operating cash flow collapsed to ¥136M and free cash flow turned negative (-¥232M), raising sustainability concerns. The balance sheet is healthy (D/E 0.42) but ROE is low at 6.4%. Overall, strong profitability is overshadowed by weak cash generation.

Income Statement

78Positive

Balance Sheet

70Positive

Cash Flow

45Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue12.14B11.86B10.76B10.59B10.60B10.20B
Gross Profit5.43B5.38B4.92B4.84B4.99B4.65B
EBITDA1.59B1.70B1.49B1.51B1.80B1.88B
Net Income824.49M885.29M722.06M701.13M833.11M862.37M
Balance Sheet
Total Assets21.79B22.44B20.95B20.87B20.62B19.64B
Cash, Cash Equivalents and Short-Term Investments2.92B2.68B2.53B2.98B2.39B2.19B
Total Debt5.75B5.79B5.18B6.05B6.13B6.13B
Total Liabilities7.93B8.65B7.91B8.52B8.80B8.52B
Stockholders Equity13.86B13.80B13.04B12.35B11.82B11.11B
Cash Flow
Free Cash Flow0-232.16M445.38M886.94M451.74M417.31M
Operating Cash Flow0136.14M666.37M1.08B618.95M655.48M
Investing Cash Flow0-379.51M-98.81M-206.25M-184.20M147.58M
Financing Cash Flow0370.84M-1.05B-307.82M-291.98M-176.25M

Koken Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price1656.00

Price Trends

50DMA1762.56Negative
100DMA1775.31Negative
200DMA1841.13Negative

Market Momentum

MACD-34.71Positive
RSI33.25Neutral
STOCH34.30Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7963, the sentiment is Negative. The current price of 1656.00 is below the 20-day moving average (MA) of 1693.75, below the 50-day MA of 1762.56, and below the 200-day MA of 1841.13, indicating a bearish trend. The MACD of -34.71 indicates Positive momentum. The RSI at 33.25 is Neutral, neither overbought nor oversold. The STOCH value of 34.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7963.

Koken Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:7963 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:6678JP:667882OutperformJPY 18.61B12.49―5.91%17.11%23.02%
JP:6823JP:682375OutperformJPY 35.66B10.26―3.29%2.48%11.44%
JP:5187JP:518774OutperformJPY 10.00B25.78―4.36%3.38%-52.61%
JP:6523JP:652361NeutralJPY 160.43B11.138.71%3.33%2.74%145.33%
JP:7963JP:796360NeutralJPY 8.14B9.84―3.02%8.56%7.14%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:7600JP:760045NeutralJPY 8.08B-5.20―5.54%-8.68%-75.03%

* General Sector Average

Performance Comparison

0%50%100%JP:7963JP:6523JP:5187JP:6678JP:6823JP:7600Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:7963 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:7963Koken Ltd.1656.00-131.75-7.37%
JP:6523PHC Holdings Corp.1260.00343.8637.53%
JP:5187Create Medic Co., Ltd.1100.00142.3314.86%
JP:6678Techno Medica Co., Ltd.2184.00300.9815.98%
JP:6823Rion Co., Ltd.2890.00461.5819.01%
JP:7600Japan Medical Dynamic Marketing, Inc.307.00-165.70-35.05%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 07, 2026